What it is
Oxytocin is a hypothalamic neuropeptide used clinically in obstetrics and studied in research for social and behavioral effects. It has a short duration of action, which is why timed dosing appears in protocol notes.
Evidence boundary
Human trial evidence exists. Keep the interpretation anchored to obstetric use and tightly defined research settings.
Trial evidence
- PMID 34068723 — Prophylactic Dose of Oxytocin for Uterine Atony during Caesarean Delivery: A Systematic Review.
- PMID 32124015 — A meta-analysis of the effects of intramuscular and intravenous injection of oxytocin on the third stage of labor.
- PMID 32592695 — Pharmacologic intervention for the management of retained placenta: a systematic review and meta-analysis of randomized trials.
- PMID 42642009 — Oxytocin as regulator of stress and inflammation in aging.
Preparation and measurement
Reconstitution: 10 mg vial + 2 mL BAC = 5 mg/mL.
Concentration matches.
Reference schedule
| Phase | Dose | Draw / measure | Frequency | Weekly total |
|---|---|---|---|---|
| Obstetric reference use | 100–500 mcg | 2–10 units (0.02–0.1 mL) | Tied to the event | Not fixed |
| Narrow research setting | Event-based dose | Event-based draw | Short-acting, timed use | Not fixed |
Obstetric reference use
- Dose
- 100–500 mcg
- Draw / measure
- 2–10 units (0.02–0.1 mL)
- Frequency
- Tied to the event
- Weekly total
- Not fixed
Narrow research setting
- Dose
- Event-based dose
- Draw / measure
- Event-based draw
- Frequency
- Short-acting, timed use
- Weekly total
- Not fixed
Weekly totals do not apply here. This is event-based use, not a daily schedule.
Titration rules
-
There is no single daily escalation ladder.
-
Keep timing tied to the actual use case.
-
Use the smallest effective event-based dose.
-
Do not generalize obstetric dosing into social or libido use.
-
Uterine tone and obstetric context
-
Social/research effects only if that is the actual use case
-
Headache or flushing
-
Nasal irritation if intranasal
-
Do not frame this as a casual bonding claim.
Practical rules
- Intranasal is the usual research route for CNS effects.
- Subcutaneous or intranasal depending on the goal.
- Keep the use case explicit.
- Rotate sites if dosing sub-Q.